By David Wild
The FDA has issued its first approval of a direct-to-consumer pharmacogenomics (PGx) test, the 23andMe Personal Genome Service (PGS). The approval and the proliferation of other consumer-oriented pharmacogenomics tests could be a boon for pharmacists, if they seize on the moment, an expert said.